Hang Li

4PUBLICATIONS
2CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 11, 2026
Immune-mediated tumor regression and subsequent escape driven by antigen loss and major histocompatibility complex (MHC) class I downregulation following GPC3 DNA vaccination in hepatocellular carcinoma.

|Oct 13, 2025
Modified hepatic arterial infusion chemotherapy protocol for reducing perioperative pain and anesthetic consumption in patients with hepatocellular carcinoma.

Hang Li, Yawei Li, Wendi Kang

|May 19, 2025
Hepatic arterial infusion chemotherapy versus systemic chemotherapy in unresectable intrahepatic cholangiocarcinoma: a propensity score-matched analysis of efficacy and safety.

Hang Li, Yawei Li, Wendi Kang

|Nov 12, 2024
Prognostic Prediction and Risk Stratification of Transarterial Chemoembolization Combined with Targeted Therapy and Immunotherapy for Unresectable Hepatocellular Carcinoma: A Dual-Center Study.

Wendi Kang, Huafei Zhao, Qicai Lian

Pageof 1

Frequent Collaborators

1 joint publications

Huafei Zhao

1 joint publications

Hao Li